Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06752499Not ApplicableCompleted

rTMS Combined With Motor Training for the Treatment of Upper Limb Motor Dysfunction in Stroke Patients

Role: collaborator

NCT07049211Not ApplicableNot Yet Recruiting

Individualized rTMS Synchronized Task Training for Closed-loop Neuromodulation of Post-stroke Motor Dysfunction

Role: collaborator

NCT06849505Not ApplicableRecruiting

Transcranial Magnetic Stimulation Synchronized with Motor Task Training for Post-Stroke Rehabilitation

Role: collaborator

All 3 trials loaded